• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    IRIDEX Corporation - Common Stock (NQ: IRIX )

    1.640 -0.070 (-4.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about IRIDEX Corporation - Common Stock

    < Previous 1 2 3 Next >
    Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Comments on Changing Glaucoma Reimbursement Landscape
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Reports Third Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    Insights into Iridex's Upcoming Earnings
    Via Benzinga
    Iridex: Q4 Earnings Insights
    Via Benzinga
    Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Appoints Patrick Mercer as Chief Executive Officer
    From IRIDEX Corporation
    Via GlobeNewswire
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024
    IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Iridex Reports Second Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex's Earnings Outlook
    Via Benzinga
    Iridex: Q3 Earnings Insights
    Via Benzinga
    Iridex Announces Convertible Note Financing
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024
    IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Iridex Reports First Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
    IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
    Advances strategic review to unlock shareholder value 
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    Earnings Scheduled For March 26, 2024
    Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
    Via Benzinga
    Iridex Corporation Receives European Patent on MicroPulse Technology
    The Advanced Short Pulse Laser System 
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
    Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment 
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Reports Third Quarter 2023 Financial Results and Business Update
    From IRIDEX Corporation
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.